Summary & Overview
HCPCS Q4288: Dermabind Dermal Adhesive, Per Square Centimeter
HCPCS Level II code Q4288 designates Dermabind charged per square centimeter as an add-on code to be reported in addition to a primary procedure for wound closure. This code matters nationally because it standardizes billing for per-square-centimeter application of a dermal adhesive product, which affects procedure-level payment reporting and product utilization tracking across outpatient and ambulatory surgical settings. Key payers included in the analysis are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare.
Readers will learn the clinical context for use of Q4288 as an adjunctive wound closure measure, typical sites of service where it is billed, and the role of add-on HCPCS Level II codes in documenting product-based charges. The publication provides benchmarks and payer coverage context where available, outlines common billing practices tied to per-square-centimeter reporting, and flags policy considerations relevant to payers and billing administrators. Data not available in the input is noted where applicable.
Billing Code Overview
HCPCS Level II code Q4288 describes Dermabind ch, per square centimeter (add-on, list separately in addition to primary procedure). This code is used to report the application of a dermal adhesive or wound closure product billed per square centimeter as an add-on service alongside a primary procedure.
-
Service type: Wound closure adjunct (dermal adhesive application)
-
Typical site of service: Ambulatory surgical centers, hospital outpatient departments, physician offices, and other procedural settings where primary surgical or wound management procedures are performed.
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient scenario involves a patient with a traumatic or surgical soft-tissue wound requiring topical adhesive reinforcement. Dermabind is billed as an add-on, per square centimeter, coded as Q4288 to report the application of cyanoacrylate tissue adhesive over a primary procedure that provides definitive wound closure (for example, suturing or staple removal). The workflow begins with wound assessment, primary closure (e.g., layered closure or simple interrupted sutures), hemostasis, and irrigating the wound. After primary closure is complete, the provider measures the area to be covered with adhesive and documents the square centimeters treated. The adhesive is applied in a thin layer over the closed incision or laceration to provide surface reinforcement, microbial barrier, and potentially improved cosmesis. Documentation should include the primary procedure code, the number of square centimeters of Dermabind applied, indication for adhesive use (e.g., tension reduction, small linear laceration overlay, or fragile skin), and any modifier(s) to explain unusual circumstances (for example, increased procedural complexity). Typical sites of service include hospital outpatient departments, ambulatory surgical centers, urgent care clinics, and office-based procedure settings where a primary wound-closure procedure is performed and the adhesive is applied as an adjunctive treatment. Common patient scenarios include repair of traumatic lacerations after motor vehicle collisions, elective excision with layered closure requiring topical reinforcement, or closure of fragile skin in elderly patients to reduce the risk of dehiscence.
Coding Specifications
| Modifier | Description | When to Use |
|---|